Last checked at 18 Dec 2019 08:00
18 December 2019
Itaconix plc ("Itaconix" or the "Company")
Itaconix Commences Trading on the US OTCQB Market
Itaconix (LSE: ITX) (OTCQB: ITXXF), a leading innovator in sustainable specialty polymers, is pleased to announce that the Company's shares will cross-trade publicly on the US OTCQB Market under the symbol ITXXF effective at the open of the US market on December 18, 2019.
Trading on the US OTC market will have no impact on the existing listing of Itaconix ordinary shares on the London Stock Exchange and no new ordinary shares were issued as part of the cross-trade. The Company will continue to rely on the announcements and disclosures it makes to the London Stock Exchange and has no Sarbanes-Oxley or SEC reporting requirements.
The cross-trade is provided through OTC Markets Group Inc., located in New York, N.Y., which operates the world's largest electronic interdealer quotation system for US broker dealers and offers multiple media channels to increase the visibility of OTC-listed companies. Independent studies show that trading on the OTC by an international company offers a positive effect on the liquidity of its shares.
John R. Shaw, Chief Executive Officer, stated: "I believe access to trading our shares in the US will benefit all of our shareholders. Our novel sustainable polymers have generated strong interest and steady support from US-based investors. Today's move onto the OTC Market facilitates investment from the United States by simplifying the trading process for potential US investors, enabling them to trade in our shares in US dollars during US trading hours."
Ends
For further information please contact:
Itaconix | +1 (603) 775 4400
|
John R. Shaw / Laura Denner | |
N+1 Singer | +44 (0) 207 496 3000 |
Richard Lindley / James Moat (Corporate Finance) Mia Gardner (Corporate Broking) |
About Itaconix
Itaconix plc (LSE: ITX) is a leading innovator in bio-based functional ingredients for improving the safety and performance of homecare, personal care, and industrial products. Its proprietary polymer technology generates a growing range of new ingredients with unique functionality that meet consumer demands for value and sustainability.
www.itaconix.com